Clinical Trials

Information about actively enrolling, ongoing, and completed clinical trials of cancer prevention, early detection, and supportive care, including phase I, II, and III agent and action trials and clinical trials management.

Clinical Trials Search

Search the DCP's clinical trials database for ongoing clinical trials in prevention, early detection, and the management of symptoms related to cancer and its treatments.

Landmark Trials

Information on landmark clinical trials that evaluated cancer prevention interventions and cancer screening tests.

Clinical Trials Management

Information for researchers about developing, reporting, and managing NCI-funded cancer prevention clinical trials.

Why I Joined a Clinical Trial

I did it not so much for me, but for my children and grandchildren. Hope that this drug will help eliminate polyps.

~ Daryl Gossen

Type(s) of Trial: Prevention

Trial Link(s): Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon Cancer

Researchers Search the Genome for Clues to Early Age Onset Cancers in Racial/Ethnic Minorities

While researchers have identified some of the genetic changes that lead to cancer development, a key knowledge gap remains: finding the genetic changes that drive the development of cancers that arise at an earlier age than average (early onset) in racially and ethnically diverse populations.

New Onset Diabetes Cohort Sought to Unravel Complexities of Pancreatic Cancer Development

The National Cancer Institute is leading a project to create a cohort of people who are newly diagnosed with diabetes in the hopes that this group, who are at increased risk of developing pancreatic cancer, provide the clues in their blood and tissues to unravel some of the unknowns about this highly fatal cancer. The New Onset Diabetes Study (NOD) will include 10,000 people ages 50 to 85...

TMIST Ramps Up to Illuminate Breast Cancer Screening

For the inaugural post of the Cancer Prevention Science blog, the focus is on the ongoing critical study of 2-D vs. 3-D mammography for breast cancer screening known as TMIST. Next time, Deborah Winn, Ph.D., acting director of the Division of Cancer Prevention, will answer questions about this research blog, and about the future of cancer prevention science....